A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

Clinical trial NCT01077622 · COMPLETED

Trial details

NCT number: NCT01077622
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukaemia, Lymphocytic, Chronic

Start date: 2009-09-01
Primary completion: 2011-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.